MARATTO

article · Clinical Breast Cancer

Evaluation of Neutrophil Activation Biomarkers in Response to Programmed Cell Death Protein-1 (PD-1) and Toll-like Receptor 9 (TLR-9) Inhibition in Triple Negative Breast Cancer

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

  • Immune cells in cancer
  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms
  • S100 Proteins and Annexins

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.clbc.2025.01.013

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.